$CGEN News

Compugen Q1 2026 Earnings Call: Complete Transcript

Leerink Partners Maintains Outperform on Compugen, Lowers Price Target to $5

Compugen Ltd. (NASDAQ:CGEN) Q1 2026 Earnings Beat Sparks 12.73% Pre-Market Rally Amid Clinical Pipeline Progress

Compugen Ltd. (CGEN) Q1 2026 Earnings Call Transcript

Compugen Q1 EPS $(0.08) Misses $(0.07) Estimate, Sales $2.176M Beat $2.095M Estimate

Lake Street Initiates Coverage On Compugen with Buy Rating, Announces Price Target of $6

Compugen Ltd (CGEN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Compugen (CGEN) Beats Q4 Earnings and Revenue Estimates

Compugen: Q4 Earnings Snapshot

Compugen Ltd. (CGEN) Q4 2025 Earnings Call Transcript

Compugen Says It Is On Track To Have MAIA-Ovarian Interim Analysis In Q1 2027

Compugen Says It Is On Track To Have MAIA-Ovarian Interim Analysis In Q1 2027

Earnings Breakdown: Compugen Q4

Compugen Q4 EPS $0.60 Beats $0.05 Estimate, Sales $67.332M Beat $1.357M Estimate

Uncovering Potential: Compugen's Earnings Preview

Kymera Therapeutics, Inc. (KYMR) Reports Q4 Loss, Misses Revenue Estimates

Acadia Pharmaceuticals (ACAD) Q4 Earnings Top Estimates

Prothena (PRTA) Reports Q4 Loss, Lags Revenue Estimates

Compugen to Participate in Upcoming Investor Conferences

Compugen to Release Fourth Quarter and Full Year 2025 Results on Monday, March 2, 2026